Chiron, Wyeth-Ayerst Research preclinical data

The companies and colleagues published in Nature Medicine the ability of an HIV gp160 vaccine and gp120 booster to produce long-term protection against HIV-1

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE